Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer Comment

被引:5
作者
O'Brien, Jonathan S. [1 ,4 ,5 ]
McVey, Aoife [1 ]
Kelly, Brian D. [1 ,4 ]
Jenjitranant, Pocharapong [1 ]
Buteau, James [2 ]
Hofman, Michael S. [2 ,4 ]
Kasivisvanithan, Veeru [1 ,6 ]
Eapen, Renu [1 ,4 ]
Moon, Daniel [1 ,4 ]
Murphy, Declan G. [1 ,4 ]
Lawrentschuk, Nathan [1 ,3 ,4 ,5 ]
机构
[1] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Prostate Canc Theranost & Imaging Ctr Excellence, Melbourne, Vic, Australia
[3] Epworth Healthcare, EJ Whitten Prostate Canc Res Ctr, Melbourne, Vic, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Dept Urol, Parkville, Vic 3050, Australia
[6] Univ Coll London Hosp Trust, Dept Urol, London, England
关键词
PSMA PET-CT; prostate cancer; staging; biochemical recurrence; government funding;
D O I
10.1111/bju.15773
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:8 / 10
页数:3
相关论文
共 6 条
[1]  
AIHW . Australian Institute for Health and Welfare, 2021, AIHW CANC SER, V133
[2]   Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial [J].
Cardet, Rafael E. de Feria ;
Hofman, Michael S. ;
Segard, Tatiana ;
Yim, Jackie ;
Williams, Scott ;
Francis, Roslyn J. ;
Frydenberg, Mark ;
Lawrentschuk, Nathan ;
Murphy, Declan G. ;
Lourenco, Richard De Abreu .
EUROPEAN UROLOGY, 2021, 79 (03) :413-418
[3]   Prospective, Multisite, International Comparison of 18F-Fluoromethylcholine PET/CT, Multiparametric MRI, and 68Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes [J].
Emmett, Louise ;
Metser, Ur ;
Bauman, Glenn ;
Hicks, Rodney J. ;
Weickhardt, Andrew ;
Davis, Ian D. ;
Punwani, Shonit ;
Pond, Greg ;
Chua, Sue ;
Ho, Bao ;
Johnston, Edward ;
Pouliot, Frederic ;
Scott, Andrew M. .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (06) :794-800
[4]   Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study [J].
Hofman, Michael S. ;
Lawrentschuk, Nathan ;
Francis, Roslyn J. ;
Tang, Colin ;
Vela, Ian ;
Thomas, Paul ;
Rutherford, Natalie ;
Martin, Jarad M. ;
Frydenberg, Mark ;
Shakher, Ramdave ;
Wong, Lih-Ming ;
Taubman, Kim ;
Lee, Sze Ting ;
Hsiao, Edward ;
Roach, Paul ;
Nottage, Michelle ;
Kirkwood, Ian ;
Hayne, Dickon ;
Link, Emma ;
Marusic, Petra ;
Matera, Anetta ;
Herschtal, Alan ;
Iravani, Amir ;
Hicks, Rodney J. ;
Williams, Scott ;
Murphy, Declan G. .
LANCET, 2020, 395 (10231) :1208-1216
[5]   Social determinants of health: does socioeconomic status affect access to staging imaging for men with prostate cancer [J].
Kelly, Brian D. ;
Perera, Marlon ;
Bolton, Damien M. ;
Papa, Nathan .
PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) :429-431
[6]   Patterns of disease detection using [18F]DCFPyL PET/CT imaging in patients with detectable PSA post prostatectomy being considered for salvage radiotherapy: a prospective trial [J].
Koschel, Samantha ;
Taubman, Kim ;
Sutherland, Thomas ;
Yap, Kelvin ;
Chao, Michael ;
Guerrieri, Mario ;
Benson, Angela ;
Starmans, Michelle ;
Byrne, Graeme ;
Ong, Grace ;
Macleod, Craig ;
Foo, Marcus ;
Wong, Lih Ming ;
Gyomber, Dennis ;
Ng, Michael .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) :3712-3722